JADE201 builds on clinical proof-of-concept for BAFF-R targeting, adding half-life extension technology to provide extended receptor occupancy ...

Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now ...

According to the Indian Council of Medical Research (ICMR), respiratory and food allergies have increased significantly over ...

We all know that asthma impacts breathing. What may be less known is that the disease, which restricts our airways due to ...

The management of urticaria is often left to allergists, but the exceptional diagnostic delay in skin of color is one argument for dermatologists to regain the lead of a major skin disorder.

ImmunityBio offers significant upside despite ongoing dilution and cash burn concerns. Click here to read an analysis of IBRX ...

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

Jade Biosciences ( ($JBIO) ) just unveiled an update. On October 6, 2025, Jade Biosciences, Inc. entered into a Securities Purchase Agreement for ...

Eight Roads-backed Plasmagen Biosciences hires Vivek Kamath, ex-Abbott India MD, to lead global expansion of plasma-based therapies.

If you've ever stared at an allergy test report and felt like it was written in an alien language, you are not alone. From IgE levels and RAST/ImmunoCAP tests to mysterious terms like Class 2 ...

Following Scientific Advice and Guidance from Scientific Advice Working Party (SAWP) of EMA, Submission of CMA Application ...